Financhill
Sell
26

TURN Quote, Financials, Valuation and Earnings

Last price:
$3.56
Seasonality move :
19.25%
Day range:
$3.47 - $3.66
52-week range:
$3.12 - $4.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.80x
Volume:
37.9K
Avg. volume:
34.9K
1-year change:
-8.08%
Market cap:
$35.9M
Revenue:
-$9.9M
EPS (TTM):
-$1.72
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $19M $5.1M $20.5M -$42.2M -$9.9M
Revenue Growth (YoY) 352.52% -73.07% 302.35% -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.4M $1.7M $1.6M $1.8M $1.8M
Other Inc / (Exp) $9.6M -$1.1M $2.1M -$3.8M -$5.7M
Operating Expenses $5.7M $4M $6.3M $2.9M $3.8M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $13.2M $1.1M $14.3M -$45M -$13.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.3K $910 $1.3K $870 $830
Net Income to Company $13.2M $1.1M $14.3M -$45M -$13.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $13.2M $1.1M $14.3M -$45M -$13.7M
 
Basic EPS (Cont. Ops) $1.26 $0.11 $1.38 -$4.34 -$1.36
Diluted EPS (Cont. Ops) $1.26 $0.11 $1.38 -$4.34 -$1.36
Weighted Average Basic Share $10.5M $10.4M $10.4M $10.4M $10.1M
Weighted Average Diluted Share $10.5M $10.4M $10.4M $10.4M $10.1M
 
EBITDA -- -- -- -- --
EBIT $13.2M $1.1M $14.3M -$45M -$13.7M
 
Revenue (Reported) $19M $5.1M $20.5M -$42.2M -$9.9M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $13.2M $1.1M $14.3M -$45M -$13.7M
Period Ending 2012-12-31 2013-12-31 2014-12-31 2015-12-31 2016-12-31
Revenue -$17.8M -$5.7M -$8.5M $4.2M -$1.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $615.9K $694.5K $835.2K $680.2K $867.2K
Other Inc / (Exp) -$1.9M $1.4M $69.2K $309.4K $2.1M
Operating Expenses $2.2M $2.1M $2M $2M $1.7M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$20M -$7.7M -$10.5M $2.2M -$3.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $2.5K $230 $70 -$2.8K
Net Income to Company -$20M -$7.7M -$10.5M $2.1M -$3.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$20M -$7.7M -$10.5M $2.1M -$3.1M
 
Basic EPS (Cont. Ops) -$1.95 -$0.75 -$0.99 $0.18 -$0.30
Diluted EPS (Cont. Ops) -$1.95 -$0.75 -$0.99 $0.18 -$0.30
Weighted Average Basic Share $10.3M $10.4M $10.4M $10.3M $10.3M
Weighted Average Diluted Share $10.3M $10.4M $10.4M $10.3M $10.3M
 
EBITDA -- -- -- -- --
EBIT -$20M -$7.6M -$10.4M $2.4M -$2.9M
 
Revenue (Reported) -$17.8M -$5.7M -$8.5M $4.2M -$1.5M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -$20M -$7.6M -$10.4M $2.4M -$2.9M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $1.4M $32.5M -$19.8M -$19.3M -$13.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.5M $1.7M $1.6M $1.7M $1.7M
Other Inc / (Exp) $13.7M -$4.6M $1.1M -$5.2M -$6.6M
Operating Expenses $5.2M $5.7M $4.3M $3.5M $4M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$3.8M $26.8M -$24.1M -$22.8M -$17.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$200 $2.3K $2.9K -$1.5K $200
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$3.9M $26.8M -$24.1M -$22.8M -$17.2M
 
Basic EPS (Cont. Ops) -$0.36 $2.58 -$2.33 -$2.19 -$1.72
Diluted EPS (Cont. Ops) -$0.37 $2.58 -$2.33 -$2.19 -$1.72
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) $1.4M $32.5M -$19.8M -$19.3M -$13.2M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $11.3M $11.5M $4.2M $655.5K $282.2K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $268K $326K $352.7K $250.4K $218.1K
Other Current Assets -- -- -- -- --
Total Current Assets $12.5M $15.4M $8.1M $1.4M $980.4K
 
Property Plant And Equipment -- -- -- $72.6K $36.1K
Long-Term Investments $87.2M $83.8M $107.5M $65.7M $50.6M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $99.8M $99.3M $115.4M $67M $51.2M
 
Accounts Payable $735.3K $735.3K $575.6K $689.2K $289.4K
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.3M $2.1M $3.9M $689.2K $289.4K
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $4.6M $2.9M $4.8M $1.4M $952.8K
 
Common Stock $334.6K $334.6K $334.6K $334.6K $334.6K
Other Common Equity Adj -- -- -- -- --
Common Equity $95.2M $96.3M $110.6M $65.5M $50.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $95.2M $96.3M $110.6M $65.5M $50.2M
 
Total Liabilities and Equity $99.8M $99.3M $115.4M $67M $51.2M
Cash and Short Terms $11.3M $11.5M $4.2M $655.5K $282.2K
Total Debt -- -- -- $72.6K $36.1K
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Cash and Equivalents $7.9M $7.6M $8M $376.4K --
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $135.2K $169.7K $183.7K $131.9K $116.8K
Other Current Assets -- -- -- -- --
Total Current Assets $9.1M $9.6M $8.6M $1.3M $412.9K
 
Property Plant And Equipment -- -- -- -- $18K
Long-Term Investments $76.3M $105.1M $79.5M $62.1M $45.8M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $85.5M $114.3M $87.9M $63.1M $46M
 
Accounts Payable $335.3K $968.8K $371K $250.3K $305.2K
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $335.3K $2.7M $371K $250.3K $305.2K
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $1.6M $3.6M $1.3M $928.9K $934.4K
 
Common Stock $334.6K $334.6K $334.6K $334.6K $334.6K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $84M $110.8M $86.6M $62.2M $45M
 
Total Liabilities and Equity $85.5M $114.3M $87.9M $63.1M $46M
Cash and Short Terms $7.9M $7.6M $8M $376.4K --
Total Debt -- -- -- $54.3K $18K
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $13.2M $1.1M $14.3M -$45M -$13.7M
Depreciation & Amoritzation $5.2K $5.5K $7.5K $9.6K $9.1K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$106.7K -$2.6M $156.3K $2.1M $262.9K
Change in Inventories -- -- -- -- --
Cash From Operations $3.5M $140.4K -$7.3M -$3.5M $1.3M
 
Capital Expenditures $4.1K $6K $10.4K $4.2K $3.7K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$4.1K -$6K -$10.4K -$4.2K -$3.7K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- -$1.7M
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- -$1.7M
 
Beginning Cash (CF) $7.8M $11.4M $11.5M $4.2M $655.5K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3.5M $134.4K -$7.4M -$3.5M -$373.3K
Ending Cash (CF) $11.4M $11.5M $4.2M $655.5K $282.2K
 
Levered Free Cash Flow $3.5M $134.4K -$7.4M -$3.5M $1.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock